UK tries out new model for gene testing in cancer patients

A tray containing cancer cells sits on an optical microscope in the Nanomedicine Lab at UCL's School of Pharmacy in LondonBy Kate Kelland LONDON (Reuters) - Britain launched a research program on Monday that should eventually allow all cancer patients to have access to the kind of genetic analysis that led Hollywood star Angelina Jolie to decide to undergo a double mastectomy. The project, involving the Institute of Cancer Research (ICR) in London, the U.S. gene sequencing firm Illumina, geneticists and cancer doctors, aims to find a way to allow more cancer genes be tested in more people. Researchers announcing the 2. ...



Affymetrix CFO Barabe to retire in June
Affymetrix Chief Financial Officer Tim Barabe is planning to retire from his post next month. The genetic testing instrument business said Monday that it is promoting Gavin Wood to the position. Barabe's ...

Stem cells recovered from cloned human embryos

This undated image made available by the Oregon Health & Science University in May 2013 shows developing cloned human embryos. Scientists have finally recovered stem cells from cloned human embryos, a longstanding goal that could lead to new treatments for such illnesses as Parkinson's disease and diabetes. In the Wednesday, May 15, 2013 edition of the journal Cell, scientists at the Oregon Health & Science University report harvesting stem cells from six embryos. Shoukhrat Mitalipov, who led the research, said the success came not from a single technical innovation, but from revising a series of steps in the process. (AP Photo/Oregon Health & Science University)NEW YORK (AP) — Scientists have finally recovered stem cells from cloned human embryos, a longstanding goal that could lead to new treatments for such illnesses as Parkinson's disease and diabetes.



Scientists Report First Success in Cloning Human Stem Cells
It’s been 17 years since Dolly the sheep was cloned from a mammary cell. And now scientists applied the same technique to make the first embryonic-stem-cell lines from human skin cells.

Idaho spud giant bets on biotech potatoes

This Friday, May 10, 2013 photo shows a genetically engineered potato poking through the soil of a planting pot inside J.R. Simplot's lab in southwestern Idaho. Simplot is seeking U.S. regulatory approval to market the potatoes _ which resist browning and are designed to produce lower levels of potentially cancer-causing acrylamide when fried _ to growers and, eventually, consumers. (AP Photo/John Miller)BOISE, Idaho (AP) — A dozen years after a customer revolt forced Monsanto to ditch its genetically engineered potato, an Idaho company aims to resurrect high-tech spuds.



Scientists create human stem cells through cloning

Handout photo showing the extraction of the nucleus from an egg cellBy Sharon Begley NEW YORK (Reuters) - After more than 15 years of failures by scientists around the world and one outright fraud, biologists have finally created human stem cells by the same technique that produced Dolly the cloned sheep in 1996: They transplanted genetic material from an adult cell into an egg whose own DNA had been removed. The result is a harvest of human embryonic stem cells, the seemingly magic cells capable of morphing into any of the 200-plus kinds that make up a person. ...



FDA approves genetic test for lung cancer drug
The Food and Drug Administration on Tuesday approved a genetic test from Roche to help doctors identify patients who can benefit from a lung cancer drug made by the company's Genentech unit. The diagnostic ...

FDA approves Roche diagnostic for gene mutation in lung cancer

Logo of Swiss pharmaceutical company Roche is pictured in Rotkreuz(Reuters) - U.S. health regulators on Tuesday approved a test developed by Roche for a specific gene mutation present in about 10 percent of non-small cell lung cancers, and said the company's drug Tarceva could be used as an initial treatment in patients with the mutation whose cancer has spread beyond the lungs. This marks the first companion diagnostic that detects epidermal growth factor receptor (EGFR) gene mutations to be approved by the U.S. Food and Drug Administration, the agency said. The diagnostic is called the Cobas EGFR Mutation Test. ...



Gene test may help guide prostate cancer treatment

Prostate cancer patient Dean Smith, left, a retired marketing executive, meets with Dr. Peter Carroll, right, at the UCSF Medical Center in San Francisco on Thursday, May 2, 2013. Carroll, chairman of urology at the University of California, San Francisco says a study he led on a new prostate cancer test - the Oncotype DX Genomic Prostate Score - suggested it could triple the number of men known to be at such low risk for aggressive disease that monitoring is a clearly safe option. Conversely, the test also suggested that some tumors were more aggressive than doctors had believed. (AP Photo/Eric Risberg)A new genetic test to gauge the aggressiveness of prostate cancer may help tens of thousands of men each year decide whether they need to treat their cancer right away or can safely monitor it.



News Summary: Gene test may help cancer treatment
BREAKTHROUGH: A new genetic test to gauge the aggressiveness of prostate cancer may help men decide whether they need to treat their cancer right away or can safely monitor it. PROVIDING ANSWERS: Doctors ...

WADA to hold meeting in China on gene doping

FILE - In this Feb. 4, 2006, file photo, IOC medical commission chairman Arne Ljungqvist responds to a question during a press conference on doping test on Austrian athletes, in Turin, Italy. Olympic officials and scientific experts will meet in in Beijing, China on June 5-6, 2013, to review the progress in developing a test for gene doping, the potential future of cheating in sports. (AP Photo/Kevork Djansezian, File)LONDON (AP) — Olympic officials and scientific experts will meet in China next month to review the progress in developing a test for gene doping, the potential future of cheating in sports.



NY biotech financier gets prison for stock scheme
A federal judge displayed anger as she handed down a four-year prison sentence Thursday to a biotechnology financier who was once among the nation's wealthiest people. U.S. District Judge Colleen McMahon ...

1    2    3    Next